The current FDMT market cap is 182.89M. The company's latest EPS is USD -2.1778 and P/E is -1.80.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 6.99M | 13.61M | 18.04M | 3.13M | 20.72M |
Operating Income | -50.76M | -56.66M | -71.33M | -110.03M | -112.87M |
Net Income | -49.31M | -56.69M | -71.32M | -107.49M | -100.84M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 58.23M | 288.33M | 353.49M | 261.85M | 339.89M |
Total Liabilities | 131.2M | 31.94M | 34.38M | 30.51M | 32.06M |
Total Equity | -72.97M | 256.39M | 319.11M | 231.34M | 307.83M |
Market Cap | 182.89M |
Price to Earnings Ratio | -1.80 |
Price to Sales Ratio | 8.78 |
Price to Cash Ratio | 0.73 |
Price to Book Ratio | 0.59 |
Dividend Yield | - |
Shares Outstanding | 46.3M |
Average Volume (1 week) | 574.93k |
Average Volume (1 Month) | 676.88k |
52 Week Change | -88.38% |
52 Week High | 36.25 |
52 Week Low | 3.66 |
Spread (Intraday) | 0.85 (19.32%) |
Company Name | 4D Molecular Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.4dmoleculartherapeutics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions